Tyler Golato
Co-Initiator 于 VitaDAO · Partner 于 Triplicate · Co-Founder 于 Molecule · Co-Initiator 于 BIO Protocol
Tyler Golato 是 Triplicate 的合伙人，也是 Molecule（一个用于药物开发的开源协议）的联合创始人。此前，他在 David M. Wilson III 博士和 Vilhelm Bohr 博士的指导下，在美国国家老龄化研究所（NIH/NIA/IRP）工作，专注于修复内源性 DNA 损伤，尤其是在衰老背景下的研究。此外，Tyler 还共同创立了 VitaDAO 和 bio.xyz。在进入 DeSci 领域之前，Tyler 作为生物化学家、分子生物学家和生物老年学家，拥有出色的早期职业生涯。
当前职位
投资
新闻提及
May in the Biosphere 🌐 - PeptAI Ignition Sale: 32x+ oversubscribed, 1.6M+ USDC committed by 1.4K+ participants. veBIO staker reward claims now live in the Bio app. Next: first on-chain wet-lab attestation via Molecule Labs in Q2. - BIO on Robinhood: $BIO is now tradable on @RobinhoodApp, bringing
The chemical universe is too massive for brute-force computing. "It would take over 170 years to brute force this data set by running inference on every single possible molecule." @metanova_labs #SN68 "Nova blueprint" incentivizes global miners to design and open-source their algorithmic shortcut
hot take: a single water molecule isn't wet. but two are.
This AI Reads Your Chemistry Instructions and Finds the Best Way to Build You a Molecule
For a decade, AI, Web3, and Bio have scaled as parallel frontiers, but that era is ending.The defining companies of the
For a decade, AI, Blockchain, and Bio have scaled as parallel frontiers - but that era is ending.The defining companies
We're excited to announce The Convergence, YZi Labs' flagship conference of the year. On May 12 at the iconic Computer H
The scientist who would have studied your disease probably chose a different problem.
Most people describe biotech companies as a jump from discovery to application.
Prompt-to-DeFi Strategist Challenge: BNB Chain Edition